//
White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry)
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
Developing and Testing a Personalized, Evidence-Based, Shared Decision-Making Tool for Stent Selection in Percutaneous Coronary Intervention Using a Pre-Post Study Design
Future of Personalized Cardiovascular Medicine